https://www.europesays.com/uk/236251/ Gene therapy brings back hearing in young and adult deaf patients #Autosomal #Children #Deafness #Ear #Gene #GeneTherapy #Genetic #Genetics #hearing #Medicine #Research #Science #Technology #UK #UnitedKingdom
#genetherapy
0 posts0 participants0 posts today
New Gene Therapy Repairs Deafness Gene, Restores Hearing In Landmark Clinical Trial;
Researchers successfully restored hearing in 10 deaf participants aged 18 months to 24 years
https://studyfinds.org/landmark-trial-gene-therapy-repairs-deafness-gene-restores-hearing/
#deafness #Deaf #hearing #GeneTherapy #biology #news #science #breakthrough
Study Finds · New Gene Therapy Repairs Deafness Gene, Restores Hearing In Landmark Clinical TrialA new gene therapy trial safely restores hearing in deaf children and adults, offering hope for those with DFNB9 deafness once thought untreatable.
Replied in thread
This could be so good for humanity.
It could also turn into a dystopian horror; I guess it’s up to us to choose.
Can we be trusted?
https://www.europesays.com/us/14058/ Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) #Business #CompetitiveAnalysis #CompoundAnnualGrowthRate #GeneTherapy #GlobalIndustry #MarketSize #Markets #UnitedStates #UnitedStates #US
Sarepta Viral Vector Gets FDA Platform Technology Designation
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier…
#Europe #UnitedStates #america #duchennemusculardystrophy #genetherapy #midcapgrowthstocks #musculardystrophy #SareptaTherapeutics #science #technology #unitedstatesofamerica #US #USFDA #USA #viralvector
https://www.europesays.com/2190686/
Sarepta Viral Vector Gets FDA Platform Technology Designation
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier…
#UnitedStates #US #USA #america #duchennemusculardystrophy #genetherapy #midcapgrowthstocks #musculardystrophy #SareptaTherapeutics #science #technology #unitedstatesofamerica #USFDA #viralvector
https://www.europesays.com/2190686/
https://www.europesays.com/2190686/ Sarepta Viral Vector Gets FDA Platform Technology Designation #america #DuchenneMuscularDystrophy #GeneTherapy #MidCapGrowthStocks #MuscularDystrophy #SareptaTherapeutics #science #technology #UnitedStates #UnitedStatesOfAmerica #US #USFDA #USA #ViralVector
https://www.alojapan.com/1279056/the-impact-of-public-insurance-on-rrso-for-hboc-in-japan-a-nationwide-data-study/ The impact of public insurance on RRSO for HBOC in Japan: a nationwide data study #CancerGenetics #GeneExpression #GeneFunction #GeneTherapy #GynaecologicalCancer #HumanGenetics #Japan #JapanNews #JapanTopics #MolecularMedicine #news JOHBOC Registration Committee: Masami Arai (Department of Clinical Genetics, Juntendo University, Graduate School of Medicine, Tokyo, Japan), Seigo Nakamura (Division of Breast Surgical Oncology, Department of Su…
What are the best ways these days for folks without institutional accounts to read recent journal articles that aren't open access? It's so disappointing not to be able to read papers like this that are all over the media.
For this one I even tried to make the free NEJM account but it didn't work.
Please don't say to email the authors.
Baby Is Healed With World’s First Personalized Gene-Editing Treatment.
The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases.
https://www.nytimes.com/2025/05/15/health/gene-editing-personalized-rare-disorders.html?unlocked_article_code=1.Hk8.wt5y.1chNUwxx815P&smid=url-share&fbclid=IwY2xjawKUeChleHRuA2FlbQIxMABicmlkETBpcWpnVEtiZnJ0S3hTclJwAR4DmWeeHkLifw6xpi6qz_UxwoMN8cWOUSF5yPLITApHCR_Z8B-bCuZw8Q8A7A_aem_BZHhad4Od2mkYpN_1s0icQ #genetics #CRISPR #genetherapy
(Just another example of why we should treasure our researchers and scientists)
Continued thread
Good news from @npr, as shared by our @ScienceDesk. A baby born in Philadelphia last August with a life-threatening genetic disorder was successfully treated with a gene-editing infusion developed using CRISPR technology. His genetic defect appears to have been fixed, at least partially reversing his condition.
https://www.europesays.com/1890162/ Ocugen Provides Business Update with Fourth Quarter and #america #Biotechnology #business #Earnings #GeneTherapy #Nasdaq:OCGN #Ocugen #ophthalmology #UnitedStates #UnitedStatesOfAmerica #US #USA
Hope for those with #SickleCell disease! 
A potential functional cure for people in #England living with #SCD has been approved for use in the #NHS.
It is a form of one-time #GeneTherapy, & researchers are having a success rate of 96.6% in patients who received the treatment.
It is #hope for those (about 4000 people in the #UK) who are eligible for a stem cell transplant, but have no match. 
DATE: December 18, 2024 at 07:30AM
SOURCE: BioWorld MedTech
Direct article link at end of text block below.
Experimental mRNA gene therapy suppresses preeclampsia in mice
#medtech #genetherapy #mRNA #preeclampsia
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------
t.coExperimental mRNA gene therapy suppresses preeclampsia in mice
DATE: December 17, 2024 at 04:30PM
SOURCE: BioWorld MedTech
Direct article link at end of text block below.
Experimental mRNA gene therapy suppresses preeclampsia in mice
#medtech #genetherapy #mRNA #preeclampsia
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------
t.coExperimental mRNA gene therapy suppresses preeclampsia in mice
DATE: November 08, 2024 at 07:00AM
SOURCE: BioWorld MedTech
Direct article link at end of text block below.
FDA eases the way for cell and gene therapy companies
#medtech @US_FDA #genetherapy #celltherapy
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------
www.bioworld.comFDA eases the way for cell and gene therapy companies
DATE: November 07, 2024 at 04:59PM
SOURCE: BioWorld MedTech
Direct article link at end of text block below.
FDA eases the way for cell and gene therapy companies
#medtech @US_FDA #genetherapy #celltherapy
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------
www.bioworld.comFDA eases the way for cell and gene therapy companies
DATE: October 25, 2024 at 07:00AM
SOURCE: BioWorld MedTech
Direct article link at end of text block below.
ESGCT 2024: Steps forward in gene and cell therapies for brain tumors
#medtech #genetherapy #celltherapy #tumor
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------
www.bioworld.comESGCT 2024: Steps forward in gene and cell therapies for brain tumors
DATE: October 24, 2024 at 04:00PM
SOURCE: BioWorld MedTech
Direct article link at end of text block below.
ESGCT 2024: Steps forward in gene and cell therapies for brain tumors
#medtech #genetherapy #celltherapy #tumor
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------
www.bioworld.comESGCT 2024: Steps forward in gene and cell therapies for brain tumors
DATE: October 24, 2024 at 07:00AM
SOURCE: BioWorld MedTech
Direct article link at end of text block below.
Japan mulls ways to boost cell, gene therapy approvals
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------
www.bioworld.comJapan mulls ways to boost cell, gene therapy approvals